Find
Board of Directors Committee Composition
= Chairman of the Board
= Chair 
= Member
= Independent Director
= Chairman of the Board
= Chair = Member
= Independent Director
| Audit | Compensation & Benefits | Finance | Nominating & Corporate Governance | Public Policy | Science & Technology | |
|---|---|---|---|---|---|---|
|
Mary Sue Coleman, Ph.D.
|
|
|
||||
|
President, University of Michigan Elected 2003 Dr. Coleman was elected to the Board of Directors in 2003 and is a member of
the Audit Committee and the Science & Technology Advisory Committee. She has
served as President of the University of Michigan since August 2002, after having
served as President of the University of Iowa from 1995 to July 2002. In addition to
her current position as President, Dr. Coleman is a professor of biological chemistry
in the University of Michigan Medical School and a professor of chemistry in the
University of Michigan College of Literature, Science and the Arts. Prior to 1995,
Dr. Coleman served as Provost and Vice President for Academic Affairs at the
University of New Mexico, Vice Chancellor for Graduate Studies & Research and
Associate Provost and Dean of Research at the University of North Carolina at
Chapel Hill, and a member of the biochemistry faculty and an administrator at the
Cancer Center of the University of Kentucky in Lexington. Elected to the National
Academy of Sciences' Institute of Medicine in 1997, Dr. Coleman is a Fellow of the
American Academy of Arts and Sciences and the American Association for the
Advancement of Science. Dr. Coleman is a Trustee of the John S. and James L.
Knight Foundation and the Gerald R. Ford Foundation. Having served as President
of two of the nation's largest and most prestigious public universities and having a
long and decorated career in the sciences, Dr. Coleman brings to the Company's
Board a unique point of view regarding organizational management and academic
research vital to a company competing in science-based industries. Other Directorships
|
||||||
|
James G. Cullen
|
|
|
|
|||
|
Retired President and Chief Operating Officer, Bell Atlantic Corporation Bell Atlantic Corporation Elected 1995 Mr. Cullen was elected to the Board of Directors in 1995 and is the Presiding
Director of the Board, Chairman of the Audit Committee and a member of the
Nominating & Corporate Governance Committee. Mr. Cullen retired as President
and Chief Operating Officer of Bell Atlantic Corporation (communications) in 2000.
He had assumed those positions in 1998, after having been Vice Chairman since
1995 and, prior to that, President since 1993. He was President and Chief
Executive Officer of Bell Atlantic-New Jersey, Inc. from 1989 to 1993. He is a
Director of Eisenhower Medical Center. With years of demonstrated managerial ability as CEO and COO of a large telecommunications company, and as the
current independent, non-executive Chairman of the Board of Directors of Agilent Technologies, Inc. and NeuStar, Inc., Mr. Cullen brings to the Company's Board a wealth of knowledge of organizational and operational management as well as board leadership experience essential to a large public company. |
||||||
|
Ian E. L. Davis
|
|
|
||||
|
Senior Advisor, Apax Partners; Former Chairman and Worldwide Managing Director, McKinsey & Company Mr. Davis was appointed to the Board of Directors in July 2010 and is a member of the Audit Committee and the Public Policy Advisory Committee. Mr. Davis is currently a Senior Advisor at Apax Partners, a private equity advisory firm.
Mr. Davis retired from McKinsey & Company (management consulting) in 2010 as a Senior Partner, having served as Chairman and Worldwide Managing Director from 2003 until 2009. In his more than 30 years at McKinsey, he served as a
consultant to a range of global organizations across the public, private and not-for-profit sectors. Prior to becoming Chairman and Worldwide Managing Director, he was Managing Partner of McKinsey's practice in the United Kingdom and Ireland. His experience includes oversight for McKinsey clients
and services in Asia, Europe, the Middle East and Africa, as well as an expertise in the consumer products and retail industries. Mr. Davis is a Director of Teach for All, a global network of independent social enterprises working to
expand educational opportunities in their nations; a non-executive Director of global energy group, BP plc.; a non-executive member of the UK's Cabinet Office Board and serves on the International Advisory Committee of the King
Abdullah Petroleum Studies and Research Centre. Having served as Chairman and Worldwide Managing Director of one of the world's leading management consulting firms, and as a consultant to a range of global organizations across the public, private and not-for-profit sectors, Mr. Davis brings considerable global experience, management insight and business knowledge to the Company's Board. |
||||||
|
Michael M.E. Johns, M.D.
|
|
|
||||
|
Chancellor, Emory University Elected 2005 Dr. Johns was elected to the Board of Directors in 2005 and is a member of the
Compensation & Benefits Committee and the Science & Technology Advisory
Committee. He has served since October 2007 as Chancellor of Emory University.
From 1996 to 2007, Dr. Johns served as Executive Vice President for Health Affairs
and Chief Executive Officer of the Robert W. Woodruff Health Sciences Center of
Emory University. As the Executive Vice President for Health Affairs, he oversaw
Emory University's widespread academic and clinical programs in health sciences
and led strategic planning initiatives for both patient care and research. In addition,
from 1996 to 2007, he served as the Chairman of the Board of Emory Healthcare,
the largest health care system in Georgia. From 1990 to 1996, Dr. Johns served as
Dean of the Johns Hopkins School of Medicine and Vice President of the Medical
Faculty at Johns Hopkins University. Dr. Johns is Past Chair of the Council of
Teaching Hospitals, a fellow of the American Association for the Advancement of
Science and a member of the Institute of Medicine. He is a member of the editorial
board of the Journal of the American Medical Association (JAMA) and chairs the
Publication Committee of the journal Academic Medicine. Having served in
numerous senior leadership positions at some of the nation's most prestigious
academic institutions, hospitals and health care systems, Dr. Johns provides a
valuable combination of experience at the highest levels of both patient care and
medical research, as well as organizational management skills and public health
policy expertise, making him an integral board member of a company in the health
care industry. |
||||||
|
Susan L. Lindquist, Ph.D.
|
|
|
||||
|
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology Massachusetts Institute of Technology Elected 2004 Dr. Lindquist was elected to the Board of Directors in 2004 and is a member of
the Science & Technology Advisory Committee and the Public Policy Advisory
Committee. She is a member of the Whitehead Institute, a non-profit, independent
research and educational institution, a Professor of Biology at the Massachusetts
Institute of Technology and an Investigator of the Howard Hughes Medical Institute.
Dr. Lindquist served as Director of the Whitehead Institute from 2001 to 2004.
Previously she was affiliated with the University of Chicago where she was the
Albert D. Lasker Professor of Medical Sciences in the Department of Molecular
Genetics and Cell Biology. Dr. Lindquist was elected to the American Academy of
Arts and Sciences in 1996, the National Academy of Sciences in 1997, the
American Philosophical Society in 2003 and the Institute of Medicine in 2006.
She received the Novartis/Drew Award for Biomedical Research in 2000, the
Dickson Prize in Medicine in 2002, the Sigma Xi William Procter Prize for
Academic Achievement in 2006, the Nevada Silver Medal for Scientific
Achievement in 2007, the Genetics Society of America Medal and the
Centennial Medal of the Harvard University Graduate School of Arts and Sciences
in 2008. In 2010, she received the Mendel Medal from the Genetics
Society (UK), The Delbrück Medal from Bayer Schering, and the National Medal of
Science (USA). She is a member of the Scientific Advisory Boards of the Stowers Institute
for Medical Research and the Institut für Molekulare Biotechnologie GmbH. She is also a Co-Founder of FoldRx Pharmaceuticals, Inc., a subsidiary
of Pfizer Inc. From her long and decorated career in scientific research and her
global reputation as a pioneer in biomedical innovation, Dr. Lindquist brings to the
Company's Board an incomparable perspective on the intersection of academic
and commercial medical research critical to a company in the health care industry. |
||||||
|
Anne M. Mulcahy
|
|
|
||||
|
Former Chairman and Chief Executive Officer, Xerox Corporation Ms. Mulcahy was appointed to the Board of Directors in 2009 and is a member of the Compensation & Benefits Committee and the Nominating & Corporate Governance Committee. Ms. Mulcahy was both Chairman and Chief Executive
Officer of Xerox Corporation (business equipment and services) until July 2009,
when she retired as CEO after eight years in the position. Prior to serving as CEO,
Ms. Mulcahy was President and Chief Operating Officer of Xerox. She has also
served as President of Xerox's General Markets Operations, which created and
sold products for reseller, dealer and retail channels. During a career at Xerox that
began in 1976, Ms. Mulcahy also served as Vice President for Human Resources
with responsibility for compensation, benefits, human resource strategy, labor
relations, management development and employee training; and Vice President
and Staff Officer for Customer Operations, covering South America and Central
America, Europe, Asia and Africa, and China. Ms. Mulcahy has been a U.S. Board
Chair of Save the Children since March 2010. Having served as Chairman and
CEO of a large, global manufacturing and services company with one of the world's
most recognized brands and track record for innovation, Ms. Mulcahy presents
valuable insight into organizational and operational management issues crucial to a
large public company, as well as a strong reputation for leadership in business
innovation and talent development. |
||||||
|
Leo F. Mullin
|
|
|
||||
|
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc. Delta Air Lines, Inc. Elected 1999 Mr. Mullin was elected to the Board of Directors in 1999 and is a member of the
Audit Committee and Chairman of the Public Policy Advisory Committee. Mr. Mullin
currently serves as a Senior Advisor, on a part-time basis, to Goldman Sachs Capital
Partners, a private equity fund group. Mr. Mullin retired as Chief Executive Officer of
Delta Air Lines, Inc. in December 2003 and Chairman in April 2004, after having served
as Chief Executive Officer of Delta since 1997 and Chairman since 1999. Mr. Mullin was
Vice Chairman of Unicom Corporation and its principal subsidiary, Commonwealth
Edison Company, from 1995 to 1997. He was an executive of First Chicago Corporation
from 1981 to 1995, serving as that company's President and Chief Operating Officer
from 1993 to 1995, and as Chairman and Chief Executive Officer of American National
Bank, a subsidiary of First Chicago Corporation, from 1991 to 1993. He is a Board
member and immediate past Board Chairman of the Juvenile Diabetes Research
Foundation (JDRF) and served as interim Chief Executive Officer of JDRF from July
through December 2008. Mr.Mullin's depth and breadth of exposure to complex issues
from having served as Chairman and CEO of one of the nation's largest airlines, and his
long and distinguished career in the banking industry, make him a skilled advisor who
provides critical insight into organizational and operational management, global
business and financial matters. |
||||||
|
William D. Perez
|
|
|
||||
|
Senior Advisor, Greenhill & Co., Inc.; Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company Wm. Wrigley Jr. Company Elected 2007 Mr. Perez was elected to the Board of Directors in 2007 and is Chairman of the Nominating & Corporate Governance Committee and a member of the Compensation & Benefits Committee.
Mr. Perez is currently a Senior Advisor at Greenhill & Co., Inc., (investment
banking). Mr. Perez served as President and Chief Executive Officer for the
Wm. Wrigley Jr. Company (confectionary and chewing gum) from 2006 to 2008.
Before joining Wrigley, Mr. Perez served as President and Chief Executive Officer
of Nike, Inc. Previously, he spent 34 years with S.C. Johnson & Son, Inc., including
eight years as its President and Chief Executive Officer. Mr. Perez is a Trustee for Cornell University and Northwestern
Memorial Hospital. With his experience as CEO of several large, consumer-focused
companies across a wide variety of industries, Mr. Perez contributes to
the Company's Board significant organizational and operational management
skills, combined with a wealth of experience in global, consumer-oriented
businesses vital to a large public company in the consumer products space. |
||||||
|
Charles Prince
|
|
|
||||
|
Senior Counselor, Albright Capital Management LLC; Retired Chairman and Chief Executive Officer, Citigroup Inc. Elected 2006 Mr. Prince was elected to the Board of Directors in 2006 and is Chairman of the Compensation & Benefits Committee and a member of the Nominating & Corporate Governance Committee. Mr. Prince is currently a Senior Counselor
for Albright Capital Management LLC, a Washington, D.C., based investment firm.
Mr. Prince served as Chief Executive Officer of Citigroup Inc. (financial services)
from 2003 to 2007 and as Chairman from 2006 to 2007. Previously he served as
Chairman and Chief Executive Officer of Citigroup's Global Corporate and
Investment Bank from 2002 to 2003, Chief Operating Officer from 2001 to 2002,
and Chief Administrative Officer from 2000 to 2001. Mr. Prince began his career as
an attorney at U.S. Steel Corporation in 1975, and in 1979 joined Commercial
Credit Company (a predecessor company to Citigroup) where he held various
management positions until 1995, when he was named Executive Vice President.
Mr. Prince is a member of the Council on Foreign Relations and The Business
Council. Having served as Chairman and CEO of the nation's largest and most
diversified financial institution, Mr. Prince brings to the Company's Board a strong
mix of organizational and operational management skills combined with well-developed
legal, global business and financial acumen critical to a large public
company. |
||||||
|
David Satcher, M.D., Ph.D.
|
|
|
||||
|
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine Morehouse School of Medicine Elected 2002 Dr. Satcher was elected to the Board of Directors in 2002 and is Chairman of the
Science & Technology Advisory Committee and a member of the Public Policy
Advisory Committee. Dr. Satcher assumed his current post at Morehouse School of
Medicine in 2004 and served as the School's Interim President from 2004 until 2006
and Director of the School's National Center for Primary Care from 2002 through
2004. In 2002, Dr. Satcher completed his four-year term as the 16th Surgeon
General of the United States. He also served as the U.S. Assistant Secretary for
Health from 1998 to 2001. From 1993 to 1998, Dr. Satcher served as Director of the
Centers for Disease Control and Prevention and Administrator of the Agency for
Toxic Substances and Disease Registry. Dr. Satcher served as President of Meharry
Medical College in Nashville, Tennessee from 1982 to 1993. Dr. Satcher is a fellow of
the American Academy of Family Physicians, the American College of Preventive
Medicine and the American College of Physicians. He has received numerous
honorary degrees and awards, including the Jimmy and Rosalynn Carter Award
for Humanitarian Contributions to the Health of Humankind, the New York Academy
of Medicine Lifetime Achievement Award and the National Association of Mental
Illness Distinguished Service Award. Dr. Satcher serves on the boards of Action for
Healthy Kids, Community Foundation of Greater Atlanta, Kaiser Family Foundation,
Save the Children and the United Way of Atlanta. With his long and decorated career
in the field of public health policy, including service as Surgeon General of the United
States, as well as his valuable experience in medical academia and patient care,
Dr. Satcher provides unparalleled experience and vision for a company in the health
care industry. |
||||||
|
William C. Weldon
|
|
|||||
|
Chairman, Board of Directors and Chief Executive Officer; Chairman, Executive Committee Johnson & Johnson Elected 2001 Mr. Weldon was elected to the Board of Directors and named Vice Chairman of
the Board in 2001 and assumed his current responsibilities in 2002. Mr. Weldon
joined the Company in 1971, and served in several sales, marketing and international
management positions before becoming President of the Company's affiliate, Ethicon Endo-Surgery, Inc. in 1992
and Company Group Chairman of Ethicon Endo-Surgery in 1995. He was appointed
to the Executive Committee and named Worldwide Chairman, Pharmaceuticals
Group, in 1998. Mr. Weldon is a
member of The Business Council, the Business Roundtable, the Executive
Committee of the Health Leadership Council, and the Sullivan Alliance to
Transform America's Health Profession. He is a Trustee of Quinnipiac University
and serves on the Liberty Science Center Chairman's Advisory Council. Mr.Weldon
also serves as Chairman of the CEO Roundtable on Cancer. Having started his
career at the Company in 1971 and been promoted to positions of increasing
responsibility across business segments, culminating with his appointment as
Chairman/CEO in 2002, Mr. Weldon brings vast knowledge of the Company's
business, structure, history and culture to the Board and the Chairman position.
Mr. Weldon continues to be one of the longest-tenured and most well-respected
CEOs in the healthcare industry. |
||||||
|
Ronald A. Williams
|
|
|
||||
|
Former Chairman and Chief Executive Officer, Aetna Inc. Elected 2011 Mr. Williams joined the Board of Directors in June 2011 and is a member of the Compensation & Benefits Committee and the Public Policy Advisory Committee. Mr. Williams served as Chairman and Chief Executive Officer of Aetna Inc. (managed care and health insurance) from 2006 to 2010, and as Chairman from 2010 until his retirement in April 2011. He currently serves on President Obama's Management Advisory Board, which is helping to bring the best of business practices to the management and operation of federal government. He is also an advisor to the private equity firm, Clayton, Dubilier & Rice, LLC, and serves as Chairman of the board of Emergency Medical Services Corporation, a leading provider of facility-based physician services and medical transportation services in the U.S. In addition, Mr. Williams lends his time and expertise to a number of organizations, such as the International Federation of Health Plans, GE Healthymagination Advisory Committee, and the Wall Street Journal CEO Council. He also serves on the boards of the Peterson Institute for International Economics and Save the Children. Previously, he served as chairman of the Council for Affordable Quality Healthcare from 2007-2010 and vice chairman of The Business Council from 2008 to 2010. With his long and distinguished career in the health care industry – from his experience leading one of Fortune's Most Admired health care companies to his career-long role as an advocate for meaningful health care reform—Mr. Williams provides the Company's Board with an exceptional combination of operational management expertise and insight into both public health care policy and the health care industry critical to a large public company in the health care industry.
|
||||||
